Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of the Predictive and Prognostic Value of Multimodalitic Imaging in the N-stage of Lung Cancer

NCT05840094 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT05840094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05840094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of the Predictive and Prognostic Value of Multimodalitic Imaging in the N-stage of Lung Cancer
Lead sponsor
Peking University First Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
May 1, 2023
Completion date
May 1, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasm of lung